Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements

News

View news from other Pharmaceutical sectors:
136-150 of 46030 results
Actavis introduces US generic specialty injectable portfolio
Actavis, a leading global specialty pharmaceutical company, announced the launch of a leading portfolio of generic specialty injectable medications to be marketed to hospitals across the United States.
News
DelMar gets notice of allowance for third US patent for VAL-083
DelMar Pharmaceuticals (DMPI) announced that the US Patent and Trademark Office (USPTO) has issued a notice of allowance for patent application number 14/083,135, entitled, "Analytical Method for Analyzing and Determining Impurities in Dianhydrogalactitol (VAL-083)".
News
KalGene signs license deal with NRC to develop new Alzheimer's therapeutics
National Research Council of Canada (NRC) has granted KalGene Pharmaceuticals an exclusive worldwide license for a therapeutic molecule against Alzheimer's disease.
News
Bellicum completes dosing in first patient cohort with BPX-501 T Cells in Phase I/II trial
By PBR Staff Writer
Bellicum Pharmaceuticals has completed dosing in the first cohort of patients in the BP-004 Phase I/II trial with its genetically engineered donor T cells (BPX-501), after receiving a partial T depleted haplo-identical allogeneic hematopoietic stem cell transplant (haplo-HSCT).
News
Boehringer, Yale University to research new immunotherapy targets
By PBR Staff Writer
Boehringer Ingelheim has entered into collaboration with Yale University to research new therapeutic targets in the field of immune-modulation, which refers to a range of treatments aimed at harnessing a patient’s immune system to fight disease.
News
Janssen, Vedanta enter license deal for lead microbiome pharmaceutical candidate
By PBR Staff Writer
Janssen Biotech has entered into a license agreement with Vedanta Biosciences for its lead microbiome pharmaceutical candidate (VE202), which showed efficacy in published preclinical studies using models of autoimmune disease.
News
Merck, Lilly to research immuno-oncology combination regimens
By PBR Staff Writer
Merck and Eli Lilly have entered into oncology clinical trial collaboration to research immuno-oncology combination regimens in multiple types of cancer.
News
PsiOxus gets positive opinion from EMA committee for ovarian cancer oncolytic vaccine
By PBR Staff Writer
UK-based biotechnology firm PsiOxus Therapeutics has secured positive opinion from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP) for an orphan medicinal product designation of its oncolytic vaccine, enadenotucirev to treat platinum-resistant epithelial ovarian cancer.
News
Novartis to sell OTC business to GSK Consumer for $17.6m
By PBR Staff Writer
Novartis India has agreed to transfer its over-the-counter division (OTC Division) to GlaxoSmithKline Consumer (GSK CPL), a consumer healthcare joint venture (JV) between Swiss pharmaceutical firm Novartis and GSK, for about INR1.097bn ($17.6m).
News
Roche enters into antibiotic license deal with Meiji and Fedora
By PBR Staff Writer
Roche has entered into a license agreement with Meiji Seika Pharma (Meiji) and Fedora to develop and commercialize OP0595, a beta-lactamase inhibitor currently in Phase I clinical development.
News
Prasco, Takeda partner to market authorized generic of Colcrys tablets in US
By PBR Staff Writer
Prasco Laboratories has entered into a distribution and supply agreement with Takeda Pharmaceuticals USA (TPUSA) for the distribution rights of Colchicine Tablets, USP, the Authorized Generic (AG) version of Colcrys (colchicine, USP) Tablets in the US.
News
Mundipharma, Purdue and Esteve partner for new pain management medicines
By PBR Staff Writer
Mundipharma Laboratories and its independent associated firm Purdue Pharmaceuticals have entered into global multi-program discovery and development collaboration with Laboratorios Esteve to develop new pain management products.
News
Elite One acquires Nutritional Labs International
Elite One Source Nutrisciences (Elite One or the Company) announced the acquisition of Nutritional Labs International of Missoula, MT (NLI).
News
Axxess Pharma gets approval to sell TapouT products to more than 2,000 independent pharmacies
Axxess Pharma, a specialty pharmaceutical and nutritional supplements company, is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands, that they have been approved by a major Canadian Distributor to sell its TapouT Muscle Spray and TapouT Pain relief Towelettes to over 2,000 independent pharmacies across Canada. This represents approximately ten percent of all Canadian pharmacies.
News
BioMarin reports positive preliminary data from Phase I/II trial of BMN 190
BioMarin Pharmaceutical announced interim results from its Phase I/II pivotal study for BMN 190 or cerliponase alfa, a recombinant human tripeptidyl peptidase 1 (rhTPP1), to treat of patients with late infantile CLN2 disease, a form of Batten disease.
News
136-150 of 46030 results